5 classes of antihypertensive drugs were not linked to positive COVID-19 test results or severe COVID-19.

Fekete, Thomas

Fekete, Thomas.

Fekete T; Lewis Katz School of Medicine of Temple University, Philadelphia, Pennsylvania, USA (T.F.).

Ann Intern Med ; 173(6): JC35, 2020 09 15.

Article in English | MEDLINE | ID: covidwho-2110753

ABSTRACT

ABSTRACT

SOURCE CITATION Reynolds HR, Adhikari S, Pulgarin C, et al. Renin-angiotensin-aldosterone system inhibitors and risk of Covid-19. N Engl J Med. 2020;3822441-8. 32356628.

Subject(s)

Coronavirus Infections; Pandemics; Pneumonia, Viral; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Betacoronavirus; COVID-19; Humans; Renin-Angiotensin System/drug effects; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pandemics Type of study: Prognostic study Limits: Humans Language: English Journal: Ann Intern Med Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google